Vascular Biogenics Ltd. (VBLT) Stock Analysis
DELISTED 2023
What happened to Vascular Biogenics Ltd. (VBLT) stock?
Vascular Biogenics Ltd. (VBLT) no longer trades on public markets. It was delisted in October 2023. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
- Delisting date:
- October 2023
- Last recorded price (historical):
- $0.156 (last quote on record before the October 2023 delisting; historical, not a current quote)
Market cap $12.1M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Vascular Biogenics Ltd. (VBLT). Vascular Biogenics Ltd. (VBLT) is a clinical-stage biopharmaceutical company focused on developing innovative therapies for cancer and immune-inflammatory diseases.
Last analyzed: Jun 14, 2026Dated analysis: the newest financial statements on file are 28 months old (Jun 1, 2024), so the figures and score below describe that period, not today.
Vascular Biogenics Ltd. (VBLT) Healthcare & Pipeline Overview
More about this archive record
Can I still buy VBLT shares?
No. VBLT stopped trading on public markets in October 2023, so the shares are not available through a broker. Anything you see quoted for VBLT elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before VBLT stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Vascular Biogenics Ltd.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.